- Home
- OMC vs BNTX Comparison
OMC vs BNTX Comparison
Compare OMC & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OMC | BNTX |
|---|---|---|
| Founded | 1944 | 2008 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Advertising | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.2B | 24.8B |
| IPO Year | 1994 | 2019 |
Fundamental Metrics
Financial Performance| Metric | OMC | BNTX |
|---|---|---|
| Price | $84.94 | $110.15 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 11 |
| Target Price | $96.17 | ★ $140.31 |
| AVG Volume (30 Days) | ★ 5.3M | 566.1K |
| Earning Date | 05-21-2026 | 01-01-0001 |
| Dividend Yield | ★ 3.78% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $17,271,900,000.00 | N/A |
| Revenue This Year | $55.00 | $2.58 |
| Revenue Next Year | $3.59 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 10.09 | N/A |
| 52 Week Low | $66.33 | $90.12 |
| 52 Week High | $89.27 | $124.00 |
Technical Indicators
Market Signals| Indicator | OMC | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 64.86 | 53.52 |
| Support Level | $69.13 | $108.55 |
| Resistance Level | N/A | $114.30 |
| Average True Range (ATR) | 3.24 | 2.79 |
| MACD | 1.72 | -0.17 |
| Stochastic Oscillator | 95.45 | 63.96 |
Price Performance
Historical ComparisonAbout OMC Omnicom Group Inc.
Omnicom is a holding company that owns several advertising agencies and related firms. It provides traditional and digital advertising services that include creative design, market research, data analytics, ad placement, and public relations. The firm operates globally, providing services in more than 70 countries; it generates more than one half of its revenue in North America and nearly 30% in Europe.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.